Real-World Cost of Care for Commercially Insured versus Medicare Patients with Metastatic Pancreatic Cancer Who Received Guideline-Recommended Therapies

Much of the literature about the costs of metastatic pancreatic cancer is focused on the Medicare population, but the cost in the commercially insured population is not well-documented. Differences in treatment patterns between commercially insured and Medicare patients with metastatic pancreatic ca...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American health & drug benefits 2021-06, Vol.14 (2), p.70-78
Hauptverfasser:	Tomicki, Samantha, Dieguez, Gabriela, Latimer, Helen, Cockrum, Paul, Kim, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!